|Place of Origin:||China|
|Minimum Order Quantity:||1000 PCS|
|Packaging Details:||100 pieces packed in a nest box|
|Supply Ability:||500000 PCS per Month|
|Product:||Drug Test 5 Multi Urine Card||Accuracy:||>99%|
IVD Medical Pathological Analysis Equipments Diagnostic Drug Test 5 Multi Urine Rapid Test Dip Card
|Product: IVD Medical diagnostic Drugtest 5 Multi urine rapid test dipcard||Instrument classification:Class II|
|Specimen:Urine||Shelf life:24 months|
|Reading time:3-5min||Parameters:5 kinds of drugs|
|Storage:Room Tempreture||Logo:Customer's Logo|
|Certificate:CE,ISO,FDA||Shipping:By sea/By air/TNT/Fedex/DHL|
Multi-Drug Urine Test Panel is a qualitative diagnostic lateral flow urinary assay for the detection of drugs of abuse in human
urine at cut-off levels specified by SAMHSA in a convenient one step multiple test strip format.
1. Total 16 drug substances can be freely composed into multi-drug test panel.
2. Cut-off levels comply with international standards.
3. Read results at 3~5 minutes.
4..Store in room temperature and valid in 24 months.
1.Each pouch contains.
2.One DOA test device.
1.Remove the test card from the sealed pouch and use it as soon as possible.
2.Remove the cap from the end of the test card. Immerse the strip(s) of the test card vertically in the urine specimen with
arrows pointing toward the urine specimen. Immerse the test card to at least the level of the wavy lines on the strip(s), but
not above the arrow(s) on the test card.
3.Remove the test card after 10 seconds and lay the card flat on a non-absorbent surface, and then begin timing.
4.Wait for colored lines to appear. Interpret the test results at 3-5 minutes. Do not read results after 10 minutes.
Interpretation Of Results:
Two lines appear. One red line should be in the control region (C), and another apparent red or pink line adjacent should be in
the test region (T). This negative result indicates that the drug concentration is below the detectable level. (*Note: The shade
of red in the test line region (T) will vary, but it should be considered negative whenever there is even a faint pink line.)
One red line appears in the control region (C). No line appears in the test region (T). This positive result indicates that the
drug concentration is above the detectable level.
Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for
control line failure. Review the procedure and repeat the test using a new test panel.
The purpose of the development of pathological analysis paper is to diagnose patients quickly, conveniently and
accurately.Now pathological analysis paper has been widely used in the world, not only self-test, but also in hospitals
and centers for disease control and prevention.The accuracy rate of a single pathological analysis paper is more
than 95%. If the results of two or more tests of different brands of test paper are the same, the test results can be
considered as 99% accurate.
Newlystar (Ningbo) Medtech Co.,Ltd. is one of the leading supplier for Pathological Analysis Equipments,
Diabetes Treatment Equipment and Finished Pharmaceutical from China. With a proven track record of
passed years,Newlystar-Medtech has been recognized by her customers as a high-quality and reliable
supplier notonly on products, but also on assistance for audit and improvement of GMP level, quality
management system, EHS management system and registration dossier support, etc.The essence of
Newlystar-Medtech's activites, is a commitment to her customers with professional service and high-quality
products with effective cost and innovative solutions.
All medical product work in Newlystar-Medtech like a bridge link the customers and Chinese manufacturers,
especially, their professional working is to make the formulation manufacturers who is familiar with
Chinese medical product to understand well the international requirement,to ensure the success of customers.
The advantages on professional working and strongly representative base on first-class manufacturing partners
in China, enable Newlystar-Medtech to provide her customers with a wide range and high-tech products,
best services and capabilities for their actions in tender, distributing and improvement in their national healthcare
system. Newlystar-Medtech also dedicates herself to sourcing quality medical products for Chinese market.